Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
YOU, Weon-Kyoo, SENNINO, Barbara, WILLIAMSON, Casey W, FALCON, Beverly, HASHIZUME, Hiroya, YAO, Li-Chin, AFTAB, Dana T, MCDONALD, Donald M
Published in Cancer research (Chicago, Ill.) (15.07.2011)
Published in Cancer research (Chicago, Ill.) (15.07.2011)
Get full text
Journal Article
Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors
Sennino, Barbara, Ishiguro-Oonuma, Toshina, Wei, Ying, Naylor, Ryan M, Williamson, Casey W, Bhagwandin, Vikash, Tabruyn, Sebastien P, You, Weon-Kyoo, Chapman, Harold A, Christensen, James G, Aftab, Dana T, McDonald, Donald M
Published in Cancer discovery (01.03.2012)
Published in Cancer discovery (01.03.2012)
Get full text
Journal Article
Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions
JINLU DAI, HONGLAI ZHANG, KARATSINIDES, Andreas, KELLER, Jill M, KOZLOFF, Kenneth M, AFTAB, Dana T, SCHIMMOLLER, Frauke, KELLER, Evan T
Published in Clinical cancer research (01.02.2014)
Published in Clinical cancer research (01.02.2014)
Get full text
Journal Article
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials
Ellingson, Benjamin M, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Zaw, Okkar, Mason, Warren P, Sahebjam, Solmaz, Abrey, Lauren E, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Lai, Albert, Nghiemphu, Phioanh L, Pope, Whitney B, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2017)
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2017)
Get full text
Journal Article
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling
Nguyen, Holly M, Ruppender, Nazanin, Zhang, Xiaotun, Brown, Lisha G, Gross, Ted S, Morrissey, Colm, Gulati, Roman, Vessella, Robert L, Schimmoller, Frauke, Aftab, Dana T, Corey, Eva
Published in PloS one (25.10.2013)
Published in PloS one (25.10.2013)
Get full text
Journal Article
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
Powles, Thomas, Choueiri, Toni K, Motzer, Robert J, Jonasch, Eric, Pal, Sumanta, Tannir, Nizar M, Signoretti, Sabina, Kaldate, Rajesh, Scheffold, Christian, Wang, Evelyn, Aftab, Dana T, Escudier, Bernard, George, Daniel J
Published in BMC cancer (07.08.2021)
Published in BMC cancer (07.08.2021)
Get full text
Journal Article
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Ellingson, Benjamin M, Gerstner, Elizabeth R, Smits, Marion, Huang, Raymond Y, Colen, Rivka, Abrey, Lauren E, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Chakhoyan, Ararat, Gahrmann, Renske, Pope, Whitney B, Leu, Kevin, Raymond, Catalina, Woodworth, Davis C, de Groot, John, Wen, Patrick Y, Batchelor, Tracy T, van den Bent, Martin J, Cloughesy, Timothy F
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
Powles, Thomas, Choueiri, Toni K, Motzer, Robert J, Jonasch, Eric, Pal, Sumanta, Tannir, Nizar M, Signoretti, Sabina, Kaldate, Rajesh, Scheffold, Christian, Wang, Evelyn, Aftab, Dana T, Escudier, Bernard, George, Daniel J
Published in BMC cancer (15.09.2021)
Published in BMC cancer (15.09.2021)
Get full text
Journal Article
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Ellingson, Benjamin M, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Chakhoyan, Ararat, Raymond, Catalina, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology (Charlottesville, Va.) (03.09.2018)
Published in Neuro-oncology (Charlottesville, Va.) (03.09.2018)
Get full text
Journal Article
Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647
GENDREAU, Steven B, VENTURA, Richard, JACKMAN, Lisa, YONGCHANG SHI, PEIWEN YU, JING WANG, AFTAB, Dana T, JAEGER, Christopher T, MEYER, Stephanie M, DE COSTA, Anushka, ENGELL, Kelly, CHEN, Jason, KEAST, Paul, MARTINI, Jean-Francois, JOLY, Alison H, LAIRD, A. Douglas, YAKES, F. Michael, WENTAO ZHANG, BENTZIEN, Frauke, CANCILLA, Belinda, LUTMAN, Jeffery, CHU, Felix
Published in Clinical cancer research (15.06.2007)
Published in Clinical cancer research (15.06.2007)
Get full text
Journal Article
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
Heller, Glenn, McCormack, Robert, Kheoh, Thian, Molina, Arturo, Smith, Matthew R, Dreicer, Robert, Saad, Fred, de Wit, Ronald, Aftab, Dana T, Hirmand, Mohammad, Limon, Ana, Fizazi, Karim, Fleisher, Martin, de Bono, Johann S, Scher, Howard I
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors
Kim, Moon H., Tsuhako, Amy Lew, Co, Erick W., Aftab, Dana T., Bentzien, Frauke, Chen, Jason, Cheng, Wei, Engst, Stefan, Goon, Levina, Klein, Rhett R., Le, Donna T., Mac, Morrison, Parks, Jason J., Qian, Fawn, Rodriquez, Monica, Stout, Thomas J., Till, Jeffrey H., Won, Kwang-Ai, Wu, Xiang, Michael Yakes, F., Yu, Peiwen, Zhang, Wentao, Zhao, Yeping, Lamb, Peter, Nuss, John M., Xu, Wei
Published in Bioorganic & medicinal chemistry letters (01.08.2012)
Published in Bioorganic & medicinal chemistry letters (01.08.2012)
Get full text
Journal Article
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
Kwilas, Anna R, Ardiani, Andressa, Donahue, Renee N, Aftab, Dana T, Hodge, James W
Published in Journal of translational medicine (13.11.2014)
Published in Journal of translational medicine (13.11.2014)
Get full text
Journal Article
Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer
Sherman, Steven I., Clary, Douglas O., Elisei, Rossella, Schlumberger, Martin J., Cohen, Ezra E. W., Schöffski, Patrick, Wirth, Lori J., Mangeshkar, Milan, Aftab, Dana T., Brose, Marcia S.
Published in Cancer (15.12.2016)
Published in Cancer (15.12.2016)
Get full text
Journal Article
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma
Ellingson, Benjamin M, Hagiwara, Akifumi, Morris, Connor J, Cho, Nicholas S, Oshima, Sonoko, Sanvito, Francesco, Oughourlian, Talia C, Telesca, Donatello, Raymond, Catalina, Abrey, Lauren E, Garcia, Josep, Aftab, Dana T, Hessel, Colin, Rachmilewitz Minei, Tamar, Harats, Dror, Nathanson, David A, Wen, Patrick Y, Cloughesy, Timothy F
Published in Clinical cancer research (13.10.2023)
Published in Clinical cancer research (13.10.2023)
Get full text
Journal Article
Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations
Gebreyohannes, Yemarshet K, Schöffski, Patrick, Van Looy, Thomas, Wellens, Jasmien, Vreys, Lise, Cornillie, Jasmien, Vanleeuw, Ulla, Aftab, Dana T, Debiec-Rychter, Maria, Sciot, Raf, Wozniak, Agnieszka
Published in Molecular cancer therapeutics (01.12.2016)
Published in Molecular cancer therapeutics (01.12.2016)
Get full text
Journal Article
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
Prasad, Gautam, Sottero, Theo, Yang, Xiaodong, Mueller, Sabine, James, C. David, Weiss, William A., Polley, Mei-Yin, Ozawa, Tomoko, Berger, Mitchel S., Aftab, Dana T., Prados, Michael D., Haas-Kogan, Daphne A.
Published in Neuro-oncology (Charlottesville, Va.) (01.04.2011)
Published in Neuro-oncology (Charlottesville, Va.) (01.04.2011)
Get full text
Journal Article
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Leibowitz-Amit, Raya, Pintilie, Melania, Khoja, Leila, Azad, Arun A, Berger, Raanan, Laird, A Douglas, Aftab, Dana T, Chi, Kim N, Joshua, Anthony M
Published in Journal of translational medicine (13.01.2016)
Published in Journal of translational medicine (13.01.2016)
Get full text
Journal Article
Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–small-cell Lung Carcinoma
Hellerstedt, Beth A., Vogelzang, Nicholas J., Kluger, Harriet M., Yasenchak, Christopher A., Aftab, Dana T., Ramies, David A., Gordon, Michael S., Lara, Primo
Published in Clinical lung cancer (01.03.2019)
Published in Clinical lung cancer (01.03.2019)
Get full text
Journal Article